Merck's newest asthma treatment, Dulera, has been FDA approved. It is in competition with Advair, which is made by GlaxoSmithKline. Dulera is expected to be available by the end of July. I'll be sure to post more about how Dulera is used once I find out more info about it!
SOURCE
No comments:
Post a Comment